Navigation Links
Discoveries in mitochondria open new field of cancer research
Date:6/20/2011

Richmond, Va. (June 20, 2011) Researchers at Virginia Commonwealth University Massey Cancer Center have revealed novel mechanisms in mitochondria that have implications for cancer as well as many other age-related diseases such as Parkinson's disease, heart disease and hypertension. This discovery has pioneered the formation of a whole new field within epigenetics research ripe with possibilities of developing future gene therapies to treat cancer and age-associated diseases.

Shirley M. Taylor, Ph.D., researcher at VCU Massey Cancer Center and associate professor in the VCU Department of Microbiology and Immunology at VCU School of Medicine, was a graduate student when her research helped establish the field of epigenetics. Epigenetics refers to the process that controls which genes get expressed in the nucleus of a cell, ultimately determining that cell's biological characteristics. Now decades later, Taylor and her colleagues have further expanded the field of epigenetics into a new area of research they created by discovering enzymes in mitochondria that were previously known to exist only in nuclei.

In mammals, all cells have two distinct genomes, which include all of an organism's hereditary information. One set exists in the nucleus while the other exists in the mitochondrion, the energy generator of the cell.

Published in the journal Proceedings of the National Academy of Sciences (PNAS), Taylor's study found two DNA modifications in the mitochondrial genome: methylated cytosine, known to function in the nucleus by "silencing" the expression of certain genes; and hydroxymethyl cytosine, which removes the silencing mark imposed by the cytosine methylation.

Together, these modifications act like a genetic on/off switch in a process known as DNA methylation. Taylor's team also showed that the enzyme responsible for DNA methylation was present in mammalian mitochondria. The presence of these DNA modifications leads the researchers to believe that a system of gene control similar to what occurs in the nucleus is present in mitochondria, functioning to ensure the correct levels of proteins needed for proper energy generation.

"In diseases such as cancer, epigenetic control is lost," says Taylor. "Genes that should be switched on are switched off and vice versa, leading to uncontrolled growth. Our research indicates that errors in gene expression could be unfolding in mitochondria, possibly contributing to loss of mitochondrial function typical of cancer and a host of other age-related diseases."

Taylor's team is currently working to force into mitochondria more of the enzyme responsible for forming the silencing mark, and to identify enzymes responsible for removing it. This should allow the researchers to observe whether these marks impact mitochondrial ability to generate energy. The researchers are also comparing the amount of DNA methylation in diseased cells versus healthy cells to determine whether mitochondrial gene expression plays a role in various diseases.

"Many diseases that afflict the elderly seem to have defects in mitochondrial function," says Taylor. "We are working to determine whether epigenetic control is a factor contributing to these defects. If so, drugs known to impact gene expression in the nucleus may be useful in reversing damage caused by improper gene expression in mitochondria."


'/>"/>

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University
Source:Eurekalert

Related biology news :

1. UC and partners awarded $23 million to transform discoveries into real-world health solutions
2. Field stations foster serendipitous discoveries in environmental, biological sciences
3. MSU discoveries upend traditional thinking about how plants make certain compounds
4. Partnership to accelerate Trudeau Institute discoveries to patient care
5. UCR plant scientists research spawns new discoveries showing how crops survive drought
6. New discoveries could improve climate projections
7. Society of Interventional Radiology highlights medical advances, new discoveries
8. Charles Drew University researcher will be honored for discoveries
9. Nanoparticle scientist speaks on new discoveries at Goldschmidt Conference
10. New discoveries in North Americas Great Plains bring ammonites to life
11. UTHealth discoveries shed more light on deadly thoracic aortic disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
Breaking Biology Technology: